Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2010 Feb 5

PMID 20129964

Citations 24

Authors

F Damond

V Avettand-Fenoel

G Collin

B Roquebert

J C Plantier

A Ganon

D Sizmann

R Babiel

J Glaubitz

M L Chaix

F Brun-Vezinet

D Descamps

C Rouzioux

Affiliations

Soon will be listed here.

Abstract

We evaluated the performance of the prototype Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, using prospective and archived clinical samples initially underquantitated by the Cobas AmpliPrep/Cobas TaqMan HIV-1 test. The performance of the new test was significantly improved, and the majority of the underquantitation observed with the first-version test was eliminated.

Citing Articles

Analysis of the Frequency of Mutations at Diagnostic Oligonucleotide Sites and Their Impact on the Efficiency of PCR for HIV-1.

Bogoslovskaya E, Tsyganova G, Nosova A, Shipulin G Microorganisms. 2023; 11(12).

PMID: 38137981 PMC: 10746099. DOI: 10.3390/microorganisms11122838.

Agile design and development of a high throughput cobas SARS-CoV-2 RT-PCR diagnostic test.

Manohar C, Sun J, Schlag P, Santini C, Fontecha M, Lotscher P Heliyon. 2022; 8(9):e10591.

PMID: 36120497 PMC: 9464314. DOI: 10.1016/j.heliyon.2022.e10591.

Evaluation of a Trio Toscana Virus Real-Time RT-PCR Assay Targeting Three Genomic Regions within Nucleoprotein Gene.

Thirion L, Pezzi L, Pedrosa-Corral I, Sanbonmatsu-Gamez S, de Lamballerie X, Falchi A Pathogens. 2021; 10(3).

PMID: 33668339 PMC: 7996202. DOI: 10.3390/pathogens10030254.

Development and Evaluation of a Duo Real-Time RT-PCR Assay Targeting Two Regions within the Genome.

Thirion L, Charrel R, Boehmann Y, Corcostegui I, Raoul H, de Lamballerie X Microorganisms. 2019; 7(12).

PMID: 31817185 PMC: 6956279. DOI: 10.3390/microorganisms7120652.

Development and Evaluation of a Duo Chikungunya Virus Real-Time RT-PCR Assay Targeting Two Regions within the Genome.

Thirion L, Pezzi L, Corcostegui I, Dubot-Peres A, Falchi A, de Lamballerie X Viruses. 2019; 11(8).

PMID: 31443243 PMC: 6722894. DOI: 10.3390/v11080755.

References

Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

Mellors J, Munoz A, Giorgi J, Margolick J, Tassoni C, Gupta P . Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997; 126(12):946-54. DOI: 10.7326/0003-4819-126-12-199706150-00003. View

Wirden M, Tubiana R, Marguet F, Leroy I, Simon A, Bonmarchand M . Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J Clin Microbiol. 2009; 47(5):1543-5. PMC: 2681834. DOI: 10.1128/JCM.02134-08. View

Alaeus A, Lidman K, Sonnerborg A, Albert J . Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 1997; 11(7):859-65. DOI: 10.1097/00002030-199707000-00004. View

Damond F, Roquebert B, Benard A, Collin G, Miceli M, Yeni P . Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J Clin Microbiol. 2007; 45(10):3436-8. PMC: 2045351. DOI: 10.1128/JCM.00973-07. View

Damond F, Apetrei C, Descamps D, Brun-Vezinet F, Simon F . HIV-1 subtypes and plasma RNA quantification. AIDS. 1999; 13(2):286-8. DOI: 10.1097/00002030-199902040-00023. View

Rouet F, Ekouevi D, Chaix M, Burgard M, Inwoley A, Tony T . Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol. 2005; 43(6):2709-17. PMC: 1151915. DOI: 10.1128/JCM.43.6.2709-2717.2005. View

Gueudin M, Plantier J, Lemee V, Schmitt M, Chartier L, Bourlet T . Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr. 2007; 44(5):500-5. DOI: 10.1097/QAI.0b013e31803260df. View

Scott L, Noble L, Moloi J, Erasmus L, Venter W, Stevens W . Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux.... J Clin Microbiol. 2009; 47(7):2209-17. PMC: 2708481. DOI: 10.1128/JCM.01761-08. View

10.

Berger A, Scherzed L, Sturmer M, Preiser W, Doerr H, Rabenau H . Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation). J Clin Virol. 2002; 25 Suppl 3:S103-7. DOI: 10.1016/s1386-6532(02)00185-3. View

11.

Schumacher W, Frick E, Kauselmann M, Maier-Hoyle V, van der Vliet R, Babiel R . Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol. 2007; 38(4):304-12. DOI: 10.1016/j.jcv.2006.12.022. View